Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GVAX colorectal cancer vaccine |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
GVAX colorectal cancer vaccine is composed of irradiated colorectal cancer (CRC) cells engineered to express GM-CSF, which induces T-cell response against CRC cells (PMID: 24832153, PMID: 31876399). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C111991 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cyclophosphamide + GVAX colorectal cancer vaccine + Pembrolizumab | Cyclophosphamide GVAX colorectal cancer vaccine Pembrolizumab | 0 | 1 |
| GVAX colorectal cancer vaccine | GVAX colorectal cancer vaccine | 0 | 2 |